Pegintron Induction Therapy in HCV Non-Responders

Summary

The purpose of this study is to compare the sustained virological response rate at 24 weeks after the end of experimental treatment (induction and 72 weeks) to that of standard 48 weeks treatment with PEG-inteferon alfa-2b and ribavirin in patients with chronic hepatitis C previous unresponsive to interferon alfa monotherapy or interferon alfa/ribavirin combination therapy.

Timeline

Start

2002-07

Primary completion

—

Completion

2005-11

Drugs

Indications